CCM
EPIX

Connective Capital Management’s ESSA Pharma EPIX Stock Holding History

Connective Capital Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-84,578
Closed -$261K – 104
2023
Q3 		$261K Sell
84,578
-58,149
-41% -$168K 0.6% 20
2023
Q2 		$385K Hold
142,727
– – 0.45% 29
2023
Q1 		$424K Buy
+142,727
New +$419K 0.63% 19

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Connective Capital Management's EPIX Position: Q4 2023 in Review

Connective Capital Management sold out of ESSA Pharma (EPIX) in Q4 2023, closing a stake of 84,578 shares — an estimated $261K sold.

Connective Capital Management first reported a position in EPIX in Q1 2023 and held it in 3 quarters. The position peaked at $424K in Q1 2023. 31 funds tracked by Wall St. Rank hold EPIX as of Q4 2023.

  • Connective Capital Management reported no remaining ESSA Pharma position as of Q4 2023 after selling out during the quarter.
  • Connective Capital Management sold 84,578 ESSA Pharma shares in Q4 2023, an estimated $261K.
  • Connective Capital Management first reported a position in ESSA Pharma in Q1 2023 and held it in 3 quarters.
  • Connective Capital Management's ESSA Pharma position peaked at $424K in Q1 2023.
  • 31 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2023.

Based on Connective Capital Management's 13F filing for Q4 2023, filed 17 May 2024.